Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 358 (9278), 265-270
- https://doi.org/10.1016/s0140-6736(01)05481-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Inhaled Glucocorticoids in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2000
- Glucocorticoid Therapy for Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1999
- ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to ClinicPulmonary Pharmacology & Therapeutics, 1999
- Chronic obstructive pulmonary disease: new opportunities for drug developmentTrends in Pharmacological Sciences, 1998
- Phosphodiesterase IsozymesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- PHOSPHODIESTERASE INHIBITORS AND ENDOTHELIN AS MODULATORS OF RESPIRATORY NEUROTRANSMISSIONClinical and Experimental Pharmacology and Physiology, 1996
- Standardization of Spirometry, 1994 Update. American Thoracic Society.American Journal of Respiratory and Critical Care Medicine, 1995
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988